ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) results from the malignant transformation of a hematopoietic stem cell, caused by oncogenic BCR-ABL1 fusion proteins with constitutive tyrosine kinase activity.